NASDAQ · DH
Healthcare · Medical - Healthcare Information Services
$1.05
Up+$0.02 (+1.94%)
Updated Sep 12, 2026, 12:43 PM
SID Score
4.2/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 20 trading sessions · Daily adjusted prices
DH closed at $1.05 after 20 trading sessions, up 64.27% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | $1.03 | $1.05 | $1.025 | $1.05 | 420.81K |
| Sep 10, 2026 | $1.04 | $1.05 | $1.025 | $1.03 | 800.61K |
| Sep 9, 2026 | $1.04 | $1.05 | $1.02 | $1.03 | 525.35K |
| Sep 8, 2026 | $1.05 | $1.05 | $1.02 | $1.02 | 776.67K |
| Sep 4, 2026 | $1.02 | $1.05 | $1.02 | $1.05 | 602.04K |
| Sep 3, 2026 | $1.05 | $1.07 | $1.02 | $1.04 | 1.01M |
| Sep 2, 2026 | $1.02 | $1.22 | $1.02 | $1.04 | 8.72M |
| Sep 1, 2026 | $0.95 | $0.9678 | $0.8779 | $0.9023 | 178.36K |
| Aug 31, 2026 | $0.80 | $1.02 | $0.795 | $0.95 | 1.12M |
| Aug 28, 2026 | $0.82 | $0.8398 | $0.7642 | $0.8024 | 190.89K |
| Aug 27, 2026 | $0.7728 | $0.8279 | $0.7728 | $0.8144 | 222.5K |
| Aug 26, 2026 | $0.76 | $0.7901 | $0.7271 | $0.7901 | 214.31K |
| Aug 25, 2026 | $0.7308 | $0.7566 | $0.7156 | $0.7542 | 89.47K |
| Aug 24, 2026 | $0.699 | $0.75 | $0.699 | $0.7209 | 155.15K |
| Aug 21, 2026 | $0.7275 | $0.735 | $0.6841 | $0.7141 | 209.57K |
| Aug 20, 2026 | $0.7098 | $0.7505 | $0.6912 | $0.7275 | 184.54K |
| Aug 19, 2026 | $0.68 | $0.72 | $0.66 | $0.718 | 204.99K |
| Aug 18, 2026 | $0.6394 | $0.7221 | $0.6314 | $0.66 | 403.27K |
| Aug 17, 2026 | $0.639 | $0.6492 | $0.6104 | $0.6394 | 274.14K |
| Aug 14, 2026 | $0.63 | $0.6478 | $0.6103 | $0.6392 | 351.87K |
The latest Smart Investors Daily articles mentioning DH.
DH research
Company profile and research snapshot.
Definitive Healthcare Corp is a provider of healthcare commercial intelligence. Its SaaS-based healthcare commercial intelligence platform is designed to provide comprehensive and accurate information on the healthcare ecosystem in the U.S. The platform uses deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers, and improving win rates with detailed contextual information. The company derives substantially all of its revenue from the sale of subscription fees for access to its platform and stand-ready support. Geographically, it derives a majority of its revenue from the United States.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 11, 2026 | Morgan Stanley | Equal-Weight | — |
| Jun 29, 2026 | B of A Securities | Underperform | — |
| Mar 30, 2026 | Barclays | Underweight | — |
| Feb 27, 2026 | Stephens & Co. | Equal-Weight | — |
| Feb 27, 2026 | Canaccord Genuity | Hold | — |
No generated briefing is available yet.
Yahoo · Sep 2, 2026
Definitive Healthcare Corp. (NASDAQ:DH) shares rose 13% on Wednesday after Advent International submitted a non-binding proposal to acquire shares and units it does not already own for $1.
Yahoo · Sep 2, 2026
FRAMINGHAM, Mass., Sept. 02, 2026 (GLOBE NEWSWIRE) -- The special committee (the “Special Committee”) of the Board of Directors of Definitive Healthcare Corp. (the “Company”) (Nasdaq: DH), an industry leader in healthcare market data and analytics, today announced that it has received a non-binding indication of interest (the “Proposal”), dated as of September 1, 2026, from Advent International, L.P., on behalf of certain of its managed funds (collectively, “Advent”), to acquire all of the outst
Yahoo · Sep 2, 2026
Mr. Ritchey brings more than 25 years of deep healthcare expertise to DefinitiveFRAMINGHAM, Mass., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare market data and analytics, today announced that its Board of Directors has appointed Clay Ritchey as the Company’s next Chief Executive Officer and as a member of the Board of Directors, each effective September 8, 2026. Mr. Ritchey succeeds Kevin Coop, who departe
Benzinga · Sep 2, 2026
Definitive Healthcare Corp. ("Definitive Healthcare") (Nasdaq: DH), an industry leader in healthcare market data and analytics, today announced that its Board of Directors has appointed Clay Ritchey as the
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning DH.
